CTONG 1104: Adjuvant Treatment with Gefitinib in NSCLC - 100459

Spotlight
Video

CTONG 1104: Adjuvant Treatment with Gefitinib in NSCLC

moasc has 207 videos Subscribe Here

Loading........
Description: Viola Zhu, MD, PhD of UC Irvine Health discusses the CTONG 1104 trial and the use of gefitinib for adjuvant treatment of patients with resected EGFR+ non-small cell lung cancer. This was recorded at the 2017 MOASC Spotlight on Clinical Oncology in Huntington Beach, CA.

Abstract 8500: CTONG 1104: Adjuvant Treatment with Gefitinib in Resected EGFR+ NSCLC.
Shared By : moasc
Posted on : 08/02/17
Added : 6 months ago



Recommended

Nothing found.

More From moasc

Nothing found.